In­novent and Lil­ly win sec­ond Chi­na OK for Tyvyt in front­line NSCLC, ramp­ing up pres­sure on king Keytru­da

In­novent Bi­o­log­ics and its part­ners at Eli Lil­ly have notched an­oth­er ar­row in their quiver in their bid to take down Mer­ck’s Keytru­da.

Chi­nese reg­u­la­tors …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER